|
New CEO boosts Glaxo (GSK)
2008-09-11 07:00:00 John Christy (http://www.thestockadvisors.co-m/ccount/click.php?id=2369) is one of the advisory industry’s leading experts on global investing. In his The Forbes International Investment Report (http://www.thestockadvisors.co-m/ccount/click.php?id=2369), he takes a look at GlaxoSmithKline (http://www.thestockadvisors.co-m/quote.htm?sym=gsk) (NYSE: GSK (http://www.thestockadvisors.co-m/quote.htm?sym=gsk)).“Th-e company recently reported second quarter 2008 earnings."And while the results were nothing spectacular — sales were up just 4%,earnings per share up just 3% — GSK’s new CEO Andrew Witty laid out a compelling vision for reshaping the business model."Emerging markets are a key element of Witty’s strategy. GSK’s emerging markets business was one of the few bright spots in the quarter, with revenue growth of15%.“Worldwide, 40% of the pharmaceutical industry’s growth is expected to come from emerging markets by 2020 as countries buy...
GlaxoSmithKline occused of hiding information on suicide risk of Paxil
2008-02-07 09:22:00 Analysis of recently released internal GlaxoSmithKline memos and reports is suggesting that GSK had obscured data indicating that Paxil (paroxetine), a popular and profitable antidepressant medication, produces an eightfold increase in suicide risk. GSK is accused of having engaged in obviously illegitimate scientific practices in the analysis and presentation of data so as to not display ...
Finland picks Glaxo for bird flu vaccine (AlertNet)
2008-01-28 00:00:00 Source: Reuters HELSINKI, Jan 25 (Reuters) - Finland said on Friday it would try to counter a possible human influenza pandemic sparked by bird flu by ordering pre-pandemic vaccines from GlaxoSmithKline ...
Sales Are Strong for Glaxo?s Weight-Loss Product (New York Times)
2007-10-24 07:35:00 Desperate for a cure for fat, consumers have purchased more than two million starter packages of the new weight-loss product Alli since it launched four months ago.
Sales Are Strong for Glaxo?s Weight-Loss Product (New York Times)
2007-10-24 07:35:00 Desperate for a cure for fat, consumers have purchased more than two million starter packages of the new weight-loss product Alli since it launched four months ago.
Glaxo: 2 Million Starter Kits of Weight Loss Pill Sold Since June (WRAL-TV
2007-10-23 05:32:00 Two million starter kits of the first over-the-counter weight loss pill approved by federal regulators were sold in the five months since it first hit shelves, GlaxoSmithKline said Monday. Glaxo has U.S. headquarters in Philadelphia and Research Triangle Park.
Glaxo: 2 million starter kits of weight loss pill sold since June (WAVY 10)
2007-10-23 04:09:00 NEW YORK (AP) - GlaxoSmithKline says two million starter kits of the first over-the-counter weight loss pill approved by federal regulators have been sold in the five months since it hit the market.
Glaxo: 2 Million Starter Kits of Weight Loss Pill Sold Since June (Local Te
2007-10-23 02:17:00 Posted: Today at 7:07 p.m. Updated: Today at 7:13 p.m. NEW YORK ? Two million starter kits of the first over-the-counter weight loss pill approved by federal regulators were sold in the five months since it first hit shelves, GlaxoSmithKline said Monday.
Glaxo to Donate Flu Vaccine for Poor
2007-06-13 20:06:00 LONDON (AP) — Pharmaceutical company GlaxoSmithKline PLC has agreed to donate 50 million doses of H5N1 vaccine to the World Health Organization in an attempt to create a pandemic vaccine stockpile for poor countries, company officials announced Wednesday…. More: continued here
FDA Declines to Fast - Track Glaxo Vaccine
2007-05-31 23:05:00 LONDON (AP) — GlaxoSmithKline PLC revealed Thursday that the U.S. Food and Drug Administration has declined to grant a priority review to its experimental cancer vaccine Cervarix, adding to pressure on the drug maker after controversy surrounding its diabetes drug Avandia…. More: continued here
Glaxo Vice President with new about to launch Alli Diet Pill
2007-05-25 20:30:00 Steven Burton, vice president weight control division of GlaxoSmithKline Consumer Healthcare, displays a starter pack of alli, the first over-the-counter diet pill approved by the Food and Drug Administration, in New York, Tuesday, May 22, 2007. In clinical trials, the FDA says that people using alli lost an additional 2 to 3 pounds for every 5 pounds lost through diet and exercise. (AP Photo/Richard Drew)
By: Alli Diet Pills
Glaxo Smith Kline (GSK) investing Rs.700 million in Pakistan
2007-04-09 11:58:00 Glaxo Smith Kline, Belgium is investing Rs.700 million towards its expansion of its existing manufacturing plants in Pakistan (Source: Privatization Commission) This offers great promise for job opportunities in Pakistan and a boost to economy. GSK is the largest exporter of Pharmaceuticals from Pakistan.
By: BuzzVines
Fda approves accelerated dosing schedule for glaxosmithkline’s twinri
2007-04-08 13:04:00 GlaxoSmithKline [NYSE:GSK] announced recently that the U.S. Food and Drug Administration (FDA) has approved TwinrixВ® [Hepatitis A Vaccine (Inactivated) and Hepatitis B (Recombinant) Vaccine], for an accelerated dosing schedule that consists of three doses given within three weeks followed by a booster dose at 12 months. [click link for full article] (Source: Liver Disease / Hepatitis News From Medical News Today) More: continued here
Glaxosmithkline files for fda approval of hpv vaccine cervarix
2007-04-04 13:04:00 GlaxoSmithKline on Thursday announced that it has filed for FDA approval of its experimental human papillomavirus vaccine Cervarix, the Philadelphia Inquirer reports (Ginsberg, Philadelphia Inquirer, 3/30). Cervarix and Merck’s HPV vaccine Gardasil have been shown to be 100% effective in preventing infection with HPV strains 16 and 18, which together cause about 70% of cervical ...
Fda approves accelerated dosing schedule for glaxosmithkline?s twinrix(r)
2007-04-04 04:04:00 GlaxoSmithKline (NYSE: GSK) announced today that the U.S. Food and Drug Administration (FDA) has approved Twinrix(R) [Hepatitis A Vaccine (Inactivated) and Hepatitis B (Recombinant) Vaccine], for an accelerated dosing schedule that consists of three doses given within three weeks followed by a booster dose at 12 months. [click link for full article] (Source: Liver ...
Glaxosmithkline submits biologics license application (bla) for cervarix
2007-04-02 14:04:00 If licensed, the vaccine will be indicated for the prevention of cervical cancer and precancerous lesions associated with the most common cancer-causing human papillomavirus types. (Source: News-Medical News Feed) More: continued here
Glaxosmithkline submits biologics license application to u.s. food and drug
2007-03-30 21:03:00 New Vaccine Candidate Developed to Protect Against Cervical Cancer - Filing Includes Data from Almost 30,000 Females PHILADELPHIA, March 29 /PRNewswire-FirstCall/ — GlaxoSmithKline (NYSE:GSK) announced today that the company has submitted a Biologics License Application (BLA) for CERVARIX(R) (human papillomavirus vaccine, AS04 adjuvant-adsorbed), its cervical cancer candidate vaccine,… (Source: Drug Newswire) More: continued here
Glaxo files for approval of globorix
2007-03-30 21:03:00 GlaxoSmithKline said Friday it filed for approval of Globorix in the European Union for using the combination meningitis vaccine in Africa. (Source: United Press International - Health Business) More: continued here
Glaxosmithkline files meningococcal conjugate vaccine
2007-03-30 20:03:00 EMEA Article 58 to speed availability in Africa’s Meningitis Belt, Middle-East and North Africa RIXENSART, Belgium, March 30 /PRNewswire-FirstCall/ — GlaxoSmithKline announced today the submission of a regulatory file to European Medicines Agency (EMEA) under Article 58 for the combination vaccine candidate Globorix(TM) (diphtheria, tetanus, pertussis, hepatitis B,… (Source: Drug Newswire) More: continued here
Glaxo files in u.s. for cervical cancer vaccine
2007-03-30 13:03:00 GlaxoSmithKline said it has applied for U.S. approval of its Cervarix vaccine to prevent cervical cancer, positioning it for a high-stakes marketing battle with Merck & Co. (Source: eWeek Health Care) More: continued here
Schoolgirls Bust Glaxo for Lying About Ribena Vitamin C
2007-03-28 16:39:00 From Boing Boing: Cory Doctorow: Cliff sez, "Here's a great story about how a science fair project carried out by two New Zealan...
GlaxoSmithKline Allies With Web For Diet Launch
2007-02-28 16:05:00 As the maker of the first weight-loss drug with regulatory approval, GlaxoSmithKline faced a dilemma: how to differentiate its product, Alli, from the many fly-by-night remedies promising weight loss without effort. To get users to buy into its assertion that long-term weight loss can only be achieved in combination with lifestyle changes, the pharma company is taking a page from Yahoo and MySpace by constructing its own portal that in many ways resembles a social network. To accomplish this, GSK is joining the ranks of advertisers that are using the Web to become content creators and build communities around their products, like Anheuser-Busch's ambitions with Bud.TV and the vibrant running community Nike has tapped with NikePlus.com. For Alli, due to launch in June or July, the Web is not just a marketing conduit, but an essential component of the product. Unlike many diet pills, Alli is marketed as a complement to a strict diet and exercise regimen. The over-the-counter drug, wh...
By: Alli Diet Pills
GlaxoSmithKlines nya "GI197111X"
2007-02-17 16:52:00 På marknaden idag finns två substanser som hämmar typ 2 respektive typ 1 och 2 av enzymet 5-alpha reduktas (vilket hjälper till i omvandlingen av testosteron till DHT). Både finasterid och dutasterid är dokumenterat kraftfulla ger i vissa fall användaren bieffekter, i synnerhet dutasterid.Varför utvecklar nu GSK en ny enzymhämmare när de har dutasterid som redan hämmar både typ-1 och typ-2 extremt bra? Substansen genomgår nu omfattande kliniska tester och när den, om den blir godkänd, når marknaden har vi ingen aning om, än.Med största sannolikhet är GSK initiativ att producera ytterligare en "dual 5-alpha reductase inhibitor" tecken på att något har hänt. Kanske har man lyckas minimera bieffekterna avsevärt? Kanske har substansen högre effektivitet? Vem vet? Lookgood vågar dock inte hoppas utan tror att hårkloning ligger närmare till än en bieffektsfri, dubbelhämmande 5-alpha reduktas hämmare med högre effektivitet.Det här inlägget är ett exempel på hur man kan resonera n...
Glaxosmithkline: state secures 2 million flu vaccine doses
2007-01-28 06:16:02 In a deal that officials said is a first, North Carolina on Friday announced a contract with GlaxoSmithKline PLC to deliver up to 2 million doses of flu vaccine to doctors and local health departments. (Source: Life) More: continued here |
|
 |
|
 |
